• Je něco špatně v tomto záznamu ?

Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis

D. Spieler, A. Velayos-Baeza, A. Mühlbäck, F. Castrop, C. Maegerlein, J. Slotta-Huspenina, B. Bader, B. Haslinger, A. Danek

. 2020 ; 8 (9) : e1179. [pub] 20200214

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020211

Grantová podpora
Wellcome Trust - United Kingdom
090532/Z/09/Z Wellcome Trust - United Kingdom

BACKGROUND: Chorea-acanthocytosis (ChAc; OMIM #200150) is a rare autosomal recessive condition with onset in early adulthood that is caused by mutations in the vacuolar protein sorting 13A (VPS13A) gene encoding chorein. Several diagnostic genomic DNA (gDNA) sequencing approaches are widely used. However, their limitations appear not to be acknowledged thoroughly enough. METHODS: Clinically, we deployed magnetic resonance imaging, blood smear analysis, and clinical chemistry for the index patient's characterization. The molecular analysis of the index patient next to his parents covered genomic DNA (gDNA) sequencing approaches, RNA/cDNA sequencing, and chorein specific Western blot. RESULTS: We report a 33-year-old male patient without functional protein due to compound heterozygosity for two VPS13A large deletions of 1168 and 1823 base pairs (bp) affecting, respectively, exons 8 and 9, and exon 13. To our knowledge, this represents the first ChAc case with two compound heterozygous large deletions identified so far. Of note, standard genomic DNA (gDNA) Sanger sequencing approaches alone yielded false negative findings. CONCLUSION: Our case demonstrates the need to carry out detection of chorein in patients suspected of having ChAc as a helpful and potentially decisive tool to establish diagnosis. Furthermore, the course of the molecular analysis in this case discloses diagnostic pitfalls in detecting some variations, such as deletions, using only standard genomic DNA (gDNA) Sanger sequencing approaches and exemplifies alternative methods, such as RNA/cDNA sequencing or qRT-PCR analysis, necessary to avoid false negative results.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020211
003      
CZ-PrNML
005      
20210830101835.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/mgg3.1179 $2 doi
035    __
$a (PubMed)32056394
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Spieler, Derek $u Department of Psychosomatic Medicine and Psychotherapy, Center for Mental Health, Faculty of Medicine, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany $u Institute of Epidemiology, Mental Health Research Unit, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany $u Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
245    10
$a Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis / $c D. Spieler, A. Velayos-Baeza, A. Mühlbäck, F. Castrop, C. Maegerlein, J. Slotta-Huspenina, B. Bader, B. Haslinger, A. Danek
520    9_
$a BACKGROUND: Chorea-acanthocytosis (ChAc; OMIM #200150) is a rare autosomal recessive condition with onset in early adulthood that is caused by mutations in the vacuolar protein sorting 13A (VPS13A) gene encoding chorein. Several diagnostic genomic DNA (gDNA) sequencing approaches are widely used. However, their limitations appear not to be acknowledged thoroughly enough. METHODS: Clinically, we deployed magnetic resonance imaging, blood smear analysis, and clinical chemistry for the index patient's characterization. The molecular analysis of the index patient next to his parents covered genomic DNA (gDNA) sequencing approaches, RNA/cDNA sequencing, and chorein specific Western blot. RESULTS: We report a 33-year-old male patient without functional protein due to compound heterozygosity for two VPS13A large deletions of 1168 and 1823 base pairs (bp) affecting, respectively, exons 8 and 9, and exon 13. To our knowledge, this represents the first ChAc case with two compound heterozygous large deletions identified so far. Of note, standard genomic DNA (gDNA) Sanger sequencing approaches alone yielded false negative findings. CONCLUSION: Our case demonstrates the need to carry out detection of chorein in patients suspected of having ChAc as a helpful and potentially decisive tool to establish diagnosis. Furthermore, the course of the molecular analysis in this case discloses diagnostic pitfalls in detecting some variations, such as deletions, using only standard genomic DNA (gDNA) Sanger sequencing approaches and exemplifies alternative methods, such as RNA/cDNA sequencing or qRT-PCR analysis, necessary to avoid false negative results.
650    _2
$a dospělí $7 D000328
650    _2
$a western blotting $x metody $7 D015153
650    12
$a delece genu $7 D017353
650    _2
$a genetické testování $x metody $7 D005820
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a choreoakantocytóza $x diagnóza $x genetika $7 D054546
650    _2
$a kvantitativní polymerázová řetězová reakce $x metody $7 D060888
650    _2
$a vezikulární transportní proteiny $x genetika $x metabolismus $7 D033921
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Velayos-Baeza, Antonio $u Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
700    1_
$a Mühlbäck, Alžbeta $u kbo-Isar-Amper-Klinikum Taufkirchen (Vils), Taufkirchen (Vils), Germany $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital Prague, Prague, Czech Republic
700    1_
$a Castrop, Florian $u Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
700    1_
$a Maegerlein, Christian $u Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
700    1_
$a Slotta-Huspenina, Julia $u Institut für Allgemeine Pathologie und Pathologische Anatomie der Technischen Universität München, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
700    1_
$a Bader, Benedikt $u Neurologische Klinik und Poliklinik, Ludwigs-Maximilians Universität München, Munich, Germany
700    1_
$a Haslinger, Bernhard $u Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
700    1_
$a Danek, Adrian $u Neurologische Klinik und Poliklinik, Ludwigs-Maximilians Universität München, Munich, Germany
773    0_
$w MED00205675 $t Molecular genetics & genomic medicine $x 2324-9269 $g Roč. 8, č. 9 (2020), s. e1179
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32056394 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101835 $b ABA008
999    __
$a ok $b bmc $g 1690912 $s 1140657
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 8 $c 9 $d e1179 $e 20200214 $i 2324-9269 $m Molecular genetics & genomic medicine $n Mol Genet Genomic Med $x MED00205675
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a 090532/Z/09/Z $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...